Table 1.

Clinicopathological characteristics of cholangiocarcinoma cohorts #1 and #2 used for methylome and miRNA analyses. Cases with pNx had no lymph nodes resected. 16 cases (ID 1-16) were used in our methylome screen.⁷

CC cohort #1
Sample ID	CC subtype	Gender	Age (years)	TNM
1	ECC	m	68	pT2, pN0, M0, G2
2	ECC	m	66	pT2, pN0, M0, G2
3	ECC	f	43	pT2, pN0, M0, G2
4	ECC	m	71	pT2, pN0, M0, G2
5	ICC	m	73	pT2, pN0, M0, G2
6	ICC	f	43	pT2, pN0, M0, G2
7	ECC	m	64	pT2, pN0, M0, G2
8	ECC	f	57	pT2, pN0, M0, G2
9	ICC	m	42	pT2, pNx, M0, G2
10	ICC	f	55	pT2, pN1, M0, G2
11	ICC	m	77	pT2, pN0, M0, G2
12	ICC	f	64	pT2, pN0, M0, G2
13	ICC	f	45	pT2, pN1, M0, G3
14	ECC	m	60	pT2, pN0, M0, G3
15	ICC	m	76	pT1, pNx, M0, G1
16	ICC	m	54	pT2, pNx, M0, G2
17	ICC	m	77	pT2, pNx, M0, G3
18	ICC	m	70	pT2, pN0, M0, G2
19	ICC	m	51	pT4, pNx, M0, G2
20	ICC	f	75	pT3, pN1, M1, G2
21	ECC	f	78	pT4, pNx, M1, G3
22	ECC	f	81	pT3, pN1, M0, G3
CC cohort #2
23	ICC	m	67	pT1, pN0, M0, G2
24	ICC	m	67	pT1, pN0, M0, G2
25	ICC	f	56	pT1, pN0, M0, G3
26	ICC	f	50	pT1, pN1, M0, G3
27	ICC	f	65	pT2, pN0, M0, G2
28	ICC	f	56	pT2, pN0, M0, G2
29	ICC	m	68	pT3, pNx, M0, G2
30	ICC	f	40	pT2, pN0, M0, G2
31	ICC	f	55	pT1, pN0, M0, G1
32	ECC	f	49	pT2, pN1, M0, G3
33	ECC	m	54	pT2, pN0, M0, G2
34	ECC	m	77	pT2, pN0, M0, G2
35	ECC	f	66	pT2, pN0, M0, G2
36	ECC	m	51	pT2, pN0, M0, G2
37	ECC	m	58	pT2, pN0, M0, G2
38	ECC	m	54	pT2, pN0, M0, G2
39	ECC	f	70	pT1, pN0, M0, G2
40	ECC	m	64	pT2, pN0, M0, G2
41	ECC	f	56	pT2, pN0, M0, G3
42	ECC	m	65	pT2, pN0, M0, G2